Caixia Pei

903 total citations
33 papers, 644 citations indexed

About

Caixia Pei is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Caixia Pei has authored 33 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 8 papers in Genetics. Recurrent topics in Caixia Pei's work include Heme Oxygenase-1 and Carbon Monoxide (15 papers), Inflammasome and immune disorders (8 papers) and High Altitude and Hypoxia (8 papers). Caixia Pei is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (15 papers), Inflammasome and immune disorders (8 papers) and High Altitude and Hypoxia (8 papers). Caixia Pei collaborates with scholars based in China, United States and Hong Kong. Caixia Pei's co-authors include Demei Huang, Yongcan Wu, Zhenxing Wang, Yilan Wang, Shihua Shi, Fei Wang, Zherui Shen, Yacong He, Xiaomin Wang and Xiaomin Wang and has published in prestigious journals such as Frontiers in Microbiology, Biochemical Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Caixia Pei

30 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Caixia Pei China	15	366	216	118	98	67	33	644
Yongcan Wu China	15	362 1.0×	218 1.0×	117 1.0×	98 1.0×	58 0.9×	30	637
Shihua Shi China	15	349 1.0×	202 0.9×	112 0.9×	81 0.8×	61 0.9×	36	629
Demei Huang China	16	378 1.0×	220 1.0×	121 1.0×	98 1.0×	69 1.0×	37	701
Zhenxing Wang China	16	412 1.1×	238 1.1×	134 1.1×	98 1.0×	80 1.2×	63	808
Zherui Shen China	13	251 0.7×	175 0.8×	97 0.8×	56 0.6×	61 0.9×	24	419
Fa Sun China	14	267 0.7×	205 0.9×	73 0.6×	18 0.2×	26 0.4×	49	610
Shakir Idris Saudi Arabia	17	161 0.4×	49 0.2×	52 0.4×	110 1.1×	56 0.8×	36	693
Xiaoli Zeng China	15	189 0.5×	107 0.5×	58 0.5×	94 1.0×	19 0.3×	45	629
Beibei Gao China	16	250 0.7×	55 0.3×	96 0.8×	40 0.4×	23 0.3×	64	737
Xiaobing Cui China	17	525 1.4×	132 0.6×	256 2.2×	32 0.3×	25 0.4×	42	1.0k

Countries citing papers authored by Caixia Pei

Since Specialization

Citations

This map shows the geographic impact of Caixia Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Caixia Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Caixia Pei more than expected).

Fields of papers citing papers by Caixia Pei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Caixia Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Caixia Pei. The network helps show where Caixia Pei may publish in the future.

Co-authorship network of co-authors of Caixia Pei

This figure shows the co-authorship network connecting the top 25 collaborators of Caixia Pei. A scholar is included among the top collaborators of Caixia Pei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Caixia Pei. Caixia Pei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Qian, Demei Huang, Junling Liu, et al.. (2025). The gut microbiota in high-altitude medicine: intersection of hypoxic adaptation and disease management. Frontiers in Microbiology. 16. 1705487–1705487.

Shen, Zherui, Qian Chen, Chen Chen, et al.. (2025). Astragaloside II pretreatment alleviates PM2.5-induced lung injury in mice via MAPK/Nrf2/GPX4 axis-mediated suppression of ferroptosis. Ecotoxicology and Environmental Safety. 302. 118613–118613.

Wang, Yilan, Ying Liu, Caixia Pei, et al.. (2024). Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injury. Biomedicine & Pharmacotherapy. 175. 116793–116793. 13 indexed citations

Huang, Demei, Yilan Wang, Caixia Pei, et al.. (2024). Pre-treatment with notoginsenoside R1 from Panax notoginseng protects against high-altitude-induced pulmonary edema by inhibiting pyroptosis through the NLRP3/caspase-1/GSDMD pathway. Biomedicine & Pharmacotherapy. 180. 117512–117512. 6 indexed citations

Liu, Junling, Caixia Pei, Zherui Shen, et al.. (2024). Preconditioning with Ginsenoside Rg3 mitigates cardiac injury induced by high-altitude hypobaric hypoxia exposure in mice by suppressing ferroptosis through inhibition of the RhoA/ROCK signaling pathway. Journal of Ethnopharmacology. 337(Pt 2). 118861–118861. 11 indexed citations

Huang, Demei, Zherui Shen, Caixia Pei, et al.. (2023). Sipeimine attenuates PM2.5-induced lung toxicity via suppression of NLRP3 inflammasome-mediated pyroptosis through activation of the PI3K/AKT pathway. Chemico-Biological Interactions. 376. 110448–110448. 14 indexed citations

Pei, Caixia, Yilan Wang, Zherui Shen, et al.. (2023). Notoginsenoside R1 protects against hypobaric hypoxia-induced high-altitude pulmonary edema by inhibiting apoptosis via ERK1/2-P90rsk-BAD ignaling pathway. European Journal of Pharmacology. 959. 176065–176065. 12 indexed citations

Huang, Demei, Caixia Pei, Zherui Shen, et al.. (2023). Rosavidin protects against PM2.5-induced lung toxicity via inhibition of NLRP3 inflammasome-mediated pyroptosis by activating the PI3K/AKT pathway. Biochemical Pharmacology. 213. 115623–115623. 8 indexed citations

Shi, Shihua, Demei Huang, Yongcan Wu, et al.. (2023). Salidroside pretreatment alleviates PM2.5 caused lung injury via inhibition of apoptosis and pyroptosis through regulating NLRP3 Inflammasome. Food and Chemical Toxicology. 177. 113858–113858. 17 indexed citations

10.

Shen, Zherui, Demei Huang, Caixia Pei, et al.. (2023). Protective effects of Eleutheroside E against high-altitude pulmonary edema by inhibiting NLRP3 inflammasome-mediated pyroptosis. Biomedicine & Pharmacotherapy. 167. 115607–115607. 13 indexed citations

11.

Shen, Zherui, Yilan Wang, Caixia Pei, et al.. (2023). Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr.etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathway. International Immunopharmacology. 121. 110423–110423. 17 indexed citations

12.

Wang, Yilan, Zherui Shen, Demei Huang, et al.. (2022). Sipeimine ameliorates PM2.5-induced lung injury by inhibiting ferroptosis via the PI3K/Akt/Nrf2 pathway: A network pharmacology approach. Ecotoxicology and Environmental Safety. 239. 113615–113615. 53 indexed citations

13.

Huang, Demei, Shihua Shi, Yilan Wang, et al.. (2022). Astragaloside IV alleviates PM2.5-caused lung toxicity by inhibiting inflammasome‐mediated pyroptosis via NLRP3/caspase-1 axis inhibition in mice. Biomedicine & Pharmacotherapy. 150. 112978–112978. 28 indexed citations

14.

Wang, Xiaomin, Shuiqin Li, Yongcan Wu, et al.. (2022). Effect of omega-3 fatty acids on TH1/TH2 polarization in individuals with high exposure to particulate matter ≤ 2.5 μm (PM2.5): a randomized, double-blind, placebo-controlled clinical study. Trials. 23(1). 179–179. 1 indexed citations

15.

Shi, Shihua, Fei Wang, Huan Yao, et al.. (2022). Oral Chinese Herbal Medicine on Immune Responses During Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Frontiers in Medicine. 8. 685734–685734. 17 indexed citations

16.

Wang, Xiaoming, Yilan Wang, Demei Huang, et al.. (2022). Astragaloside IV regulates the ferroptosis signaling pathway via the Nrf2/SLC7A11/GPX4 axis to inhibit PM2.5-mediated lung injury in mice. International Immunopharmacology. 112. 109186–109186. 106 indexed citations

17.

Pei, Caixia, Fei Wang, Demei Huang, et al.. (2021). Astragaloside IV Protects from PM2.5-Induced Lung Injury by Regulating Autophagy via Inhibition of PI3K/Akt/mTOR Signaling in vivo and in vitro. Journal of Inflammation Research. Volume 14. 4707–4721. 45 indexed citations

18.

Wu, Yongcan, Demei Huang, Xiaomin Wang, et al.. (2021). Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats. International Immunopharmacology. 96. 107621–107621. 34 indexed citations

19.

Wu, Yongcan, Wei Xiao, Caixia Pei, et al.. (2020). Astragaloside IV alleviates PM2.5-induced lung injury in rats by modulating TLR4/MyD88/NF-κB signalling pathway. International Immunopharmacology. 91. 107290–107290. 38 indexed citations

20.

Wu, Yongcan, Caixia Pei, Xiaomin Wang, et al.. (2020). Effect of probiotics on nasal and intestinal microbiota in people with high exposure to particulate matter ≤ 2.5 μm (PM2.5): a randomized, double-blind, placebo-controlled clinical study. Trials. 21(1). 850–850. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact